HIV Antibodies

"HIV Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibodies reactive with HIV ANTIGENS.

Descriptor ID	D015483
MeSH Number(s)	D12.776.124.486.485.114.254.150.440 D12.776.124.790.651.114.254.150.440 D12.776.377.715.548.114.254.150.440
Concept/Terms	HIV Antibodies HIV Antibodies Antibodies, HIV HIV Associated Antibodies Antibodies, HIV Associated HIV-Associated Antibodies Antibodies, HIV-Associated HTLV III Antibodies Antibodies, HTLV III HTLV III LAV Antibodies T-Lymphotropic Virus Type III Antibodies, Human HTLV-III-LAV Antibodies Antibodies, HTLV-III-LAV LAV Antibodies Antibodies, LAV Lymphadenopathy Associated Antibodies Antibodies, Lymphadenopathy Associated Lymphadenopathy-Associated Antibodies Antibodies, Lymphadenopathy-Associated T Lymphotropic Virus Type III Antibodies, Human AIDS Antibodies Antibodies, AIDS HTLV-III Antibodies Antibodies, HTLV-III

Below are MeSH descriptors whose meaning is more general than "HIV Antibodies".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Antibodies, Viral [D12.776.124.486.485.114.254]
Deltaretrovirus Antibodies [D12.776.124.486.485.114.254.150]
HIV Antibodies [D12.776.124.486.485.114.254.150.440]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Antibodies, Viral [D12.776.124.790.651.114.254]
Deltaretrovirus Antibodies [D12.776.124.790.651.114.254.150]
HIV Antibodies [D12.776.124.790.651.114.254.150.440]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Antibodies, Viral [D12.776.377.715.548.114.254]
Deltaretrovirus Antibodies [D12.776.377.715.548.114.254.150]
HIV Antibodies [D12.776.377.715.548.114.254.150.440]

Below are MeSH descriptors whose meaning is related to "HIV Antibodies".

Below are MeSH descriptors whose meaning is more specific than "HIV Antibodies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Antibodies" by people in this website by year, and whether "HIV Antibodies" was a major or minor topic of these publications.

Bar chart showing 13 publications over 11 distinct years, with a maximum of 2 publications in 2002 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2004	0	1	1
2005	0	1	1
2007	0	1	1
2008	0	1	1
2010	0	1	1
2012	2	0	2
2014	0	1	1
2015	1	0	1
2022	0	1	1
2023	0	1	1

Below are the most recent publications written about "HIV Antibodies" by people in Profiles.

Tebas P, Lynn K, Azzoni L, Cocchella G, Papasavvas E, Fair M, Karanam B, Sharma P, Reeves JD, Petropoulos CJ, Lalley-Chareczko L, Kostman JR, Short W, Mounzer K, Montaner LJ. Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons. AIDS. 2023 Jul 01; 37(8):1203-1207.

View in: PubMed
Schapiro HM, Khasnis MD, Ahn K, Karagiaridi A, Hayden S, Cilento ME, Root MJ. Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env. PLoS Pathog. 2022 May; 18(5):e1010531.

View in: PubMed
Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL. Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins. Viral Immunol. 2016 Jan-Feb; 29(1):64-70.

View in: PubMed
Pham-Thomas N, Pereira N, Powell AM, Croft DJ, Guilfoil DS, Montgomery OC. Outcomes of effective transmission of electronic prenatal records from the office to the hospital. Obstet Gynecol. 2014 Aug; 124(2 Pt 1):317-322.

View in: PubMed
Kobie JJ, Alcena DC, Zheng B, Bryk P, Mattiacio JL, Brewer M, Labranche C, Young FM, Dewhurst S, Montefiori DC, Rosenberg AF, Feng C, Jin X, Keefer MC, Sanz I. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity. PLoS One. 2012; 7(4):e35356.

View in: PubMed
Cragin L, Pan F, Peng S, Zenilman JM, Green J, Doucet C, Chalfin DB, de Lissovoy G. Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States. HIV Clin Trials. 2012 Jan-Feb; 13(1):11-22.

View in: PubMed
Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 2010 Dec 10; 29(1):130-40.

View in: PubMed
Hurwitz JL, Zhan X, Brown SA, Bonsignori M, Stambas J, Lockey TD, Sealy R, Surman S, Freiden P, Jones B, Martin L, Blanchard J, Slobod KS. HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail. Front Biosci. 2008 Jan 01; 13:609-20.

View in: PubMed
Wiznia A, Church J, Emmanuel P, Eppes S, Rowell L, Evans C, Bertasso A. Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients. Pediatr Infect Dis J. 2007 Sep; 26(9):799-805.

View in: PubMed
Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ. Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach. Virology. 2005 Jan 5; 331(1):82-93.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement